What are Mission Vision & Core Values of Sandoz Group Company?

The core of the Sandoz Mission revolves around ensuring that essential medicines are within reach for everyone, regardless of their location or economic status. This commitment is particularly evident in their focus on generic and biosimilar medicines. These alternatives offer significant cost savings compared to their originator counterparts, making treatments accessible to a broader patient population and contributing to the sustainability of healthcare systems globally.

Sandoz directly targets patients and healthcare systems. The Sandoz Group understands that patients are at the center of their mission, and their needs drive their product development and distribution strategies. Simultaneously, they work closely with healthcare systems to provide cost-effective solutions that alleviate financial burdens and improve overall healthcare delivery. This dual focus ensures that their mission translates into tangible benefits for all stakeholders.

The Sandoz Pharmaceuticals portfolio is vast, encompassing approximately 1,300 products. This diverse range covers various therapeutic areas, from common ailments to complex diseases, ensuring that patients have access to a wide array of essential treatments. Their commitment to a broad portfolio underscores their dedication to addressing diverse healthcare needs and providing comprehensive solutions.

Biosimilars are a critical element of the Sandoz Mission. These advanced medicines offer more affordable alternatives to complex biological drugs. Sandoz has an industry-leading pipeline of 28 biosimilar molecules, demonstrating their commitment to expanding access in this rapidly growing segment. This focus on biosimilars highlights their dedication to innovation and their role in shaping the future of medicine.

In 2024, Sandoz provided over 900 million patient treatments, a clear demonstration of their mission in action. This significant number underscores their impact on global healthcare and their ability to reach a vast patient population. These figures showcase the tangible results of their commitment to making medicines accessible.

The Sandoz Company mission is inherently customer-centric. By prioritizing the needs of patients and healthcare systems, Sandoz ensures that its products and services directly address the challenges and demands of the healthcare landscape. This patient-focused approach is a cornerstone of their strategy and a key driver of their success. For a deeper understanding of their strategies, consider reading about the Marketing Strategy of Sandoz Group.

The core of the Sandoz Vision is to achieve market leadership. This includes a strong focus on the biosimilars segment, particularly in the United States. They aim to significantly improve their current market position and become a top player.

The Sandoz Vision has a global scope, reflecting the company's international presence. Sandoz operates across Europe, North America, and other international markets. Their goal is to be a leader in the generics and biosimilars space worldwide.

Based on Sandoz's current trajectory, the vision appears both ambitious and achievable. In 2024, Sandoz demonstrated robust performance with a 9% net sales growth in constant currencies. This growth was significantly driven by a 30% increase in biosimilar sales.

Sandoz has a strong pipeline of 28 biosimilars. This pipeline supports their ambition for leadership in the biosimilars area. Planned launches in key markets like the US and Europe in 2025 are critical to achieving their vision.

The vision of being "most valued" suggests that Sandoz is not only focused on financial performance but also on its positive impact on society. This aligns with their mission of pioneering access to medicines, demonstrating a commitment to both business success and social responsibility.

The Sandoz Vision is closely aligned with its strategic goals. The company's investments in research and development, particularly in biosimilars, and its focus on expanding its global footprint are all geared towards achieving this vision. Understanding the company's leadership, like the Owners & Shareholders of Sandoz Group, is crucial to understanding the vision.

The Sandoz Mission and Sandoz Vision shape day-to-day operations, fostering a culture centered on patient needs and access. Long-term planning is guided by the company's ambition for market leadership and its commitment to sustainable growth and social impact.

CEO Richard Saynor has consistently emphasized the link between strategy and purpose, highlighting the company's "growing track record of execution and performance." This emphasizes the importance of aligning actions with the Sandoz Core Values and overall mission.

The focus on generics and biosimilars is a direct response to market needs and the company's mission to provide affordable medicines. The growth in the biosimilars market, as a result, is a key driver for Sandoz's future success. The company's commitment to this sector is a key element of its long-term strategy.

Sandoz's global presence is a testament to its mission of expanding access to medicines. The company operates in numerous countries, ensuring that its products reach patients worldwide. This global reach is a critical component of its mission.

Sandoz's commitment to sustainable growth and social impact underscores its long-term vision. The company recognizes the importance of responsible business practices in achieving its mission. This includes initiatives related to environmental sustainability and social responsibility.

The robust pipeline of biosimilars and the focus on innovation give Sandoz a competitive edge in the market. The company's ability to develop and bring new products to market quickly is a key factor in its success. This focus on innovation is directly linked to its commitment to its mission.

Leadership plays a critical role in ensuring that the Sandoz mission and vision are consistently communicated and upheld throughout the organization. CEO Richard Saynor and the leadership team actively champion the company's core principles.

Sandoz effectively communicates its mission and vision to all stakeholders through multiple channels. This transparency builds trust and ensures alignment across the board.

While specific programs are not explicitly detailed, Sandoz embeds its core values through its company culture, performance management systems, and leadership communication. These mechanisms help ensure that the company's principles are consistently applied.

The approval of the 2024 Annual Financial Statements and the report on non-financial matters by shareholders at the Annual General Meeting in April 2025 signifies alignment on the company's direction and performance against its stated goals. This shows how the company's strategy is working and providing a positive return.